APO RESEARCH · REPORT
Ambulatory Infusion Therapy Services
Infusion therapy involves the administration of medication through a needle or catheter. It is prescribed when a patient’s condition is so severe that it cannot be treated effectively by oral medications.
Product & engineering
Understand the product.
Infusion therapy involves the administration of medication through a needle or catheter. It is prescribed when a patient’s condition is so severe that it cannot be treated effectively by oral medications.
Ambulatory infusion therapy is a flourishing nationwide trend. Due to a confluence of health care trends, such as an upsurge in specialty medications that require expert-level administration, a population increasing in age, and steep health care costs, a challenging, but lucrative opportunity for pharmacies and pharmacists alike has begun to emerge.
Selected research
Market Outlook & Growth Opportunities
Global Ambulatory Infusion Therapy Services Market Outlook and Growth Opportunities 2026
Market perspective
Infusion therapy involves the administration of medication through a needle or catheter. It is prescribed when a patient’s condition is so severe that it cannot be treated effectively by oral medications.
Ambulatory infusion therapy is a flourishing nationwide trend. Due to a confluence of health care trends, such as an upsurge in specialty medications that require expert-level administration, a population increasing in age, and steep health care costs, a challenging, but lucrative opportunity for pharmacies and pharmacists alike has begun to emerge.
The leading players mainly are Option Care Health, Coram CVS, UnitedHealth Group, HCA Healthcare, McLaren, CHI Health, Accredo Health, PharMerica, Cleveland Clinic, etc. The market is very fragmented because of numerous hospital outpatient infusion services and clinic services
Read the full market overview
This report provides an overview of the global Ambulatory Infusion Therapy Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Ambulatory Infusion Therapy Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Ambulatory Infusion Therapy Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Ambulatory Infusion Therapy Services market.
Ambulatory Infusion Therapy Services Segment by Company
Option Care Health
Coram CVS
UnitedHealth Group
HCA Healthcare
McLaren
CHI Health
Accredo Health
PharMerica
Cleveland Clinic
Ambulatory Infusion Therapy Services Segment by Type
Anticoagulation therapy
Chemotherapy
Anti-infective therapies
Hydration therapy
Immune therapy (Ig)
Specialty Injectables
IV Steroids
Wound Care
General Nursing Services
Ambulatory Infusion Therapy Services Segment by Application
Hospital
Clinic
Home
Ambulatory Infusion Therapy Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Ambulatory Infusion Therapy Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Ambulatory Infusion Therapy Services key companies, revenue, market share, and recent developments.
3. To split the Ambulatory Infusion Therapy Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Ambulatory Infusion Therapy Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Ambulatory Infusion Therapy Services significant trends, drivers, influence factors in global and regions.
6. To analyze Ambulatory Infusion Therapy Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ambulatory Infusion Therapy Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ambulatory Infusion Therapy Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ambulatory Infusion Therapy Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ambulatory Infusion Therapy Services industry.
Chapter 3: Detailed analysis of Ambulatory Infusion Therapy Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Ambulatory Infusion Therapy Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Ambulatory Infusion Therapy Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Ambulatory Infusion Therapy Services Industry Trends
Table 2. Ambulatory Infusion Therapy Services Industry Drivers
Table 3. Ambulatory Infusion Therapy Services Industry Opportunities and Challenges
Table 4. Ambulatory Infusion Therapy Services Industry Restraints
Table 5. Global Ambulatory Infusion Therapy Services Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Ambulatory Infusion Therapy Services Revenue Share by Company (2021-2026)
Table 7. Global Ambulatory Infusion Therapy Services Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Ambulatory Infusion Therapy Services Key Company Manufacturing Base & Headquarters
Table 9. Global Ambulatory Infusion Therapy Services Company, Product Type & Application
Table 10. Global Ambulatory Infusion Therapy Services Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Ambulatory Infusion Therapy Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Anticoagulation therapy
Table 15. Significant Companies of Chemotherapy
Table 16. Significant Companies of Anti-infective therapies
Table 17. Significant Companies of Hydration therapy
Table 18. Significant Companies of Immune therapy (Ig)
Table 19. Significant Companies of Specialty Injectables
Table 20. Significant Companies of IV Steroids
Table 21. Significant Companies of Wound Care
Table 22. Significant Companies of General Nursing Services
Table 23. Global Ambulatory Infusion Therapy Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 24. Global Ambulatory Infusion Therapy Services Sales Value by Type (2021-2026) & (US$ Million)
Table 25. Global Ambulatory Infusion Therapy Services Sales Value by Type (2027-2032) & (US$ Million)
Table 26. Global Ambulatory Infusion Therapy Services Sales Value Share by Type (2021-2026)
Table 27. Global Ambulatory Infusion Therapy Services Sales Value Share by Type (2027-2032)
Table 28. Significant Companies of Hospital
Table 29. Significant Companies of Clinic
Table 30. Significant Companies of Home
Table 31. Global Ambulatory Infusion Therapy Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 32. Global Ambulatory Infusion Therapy Services Sales Value by Application (2021-2026) & (US$ Million)
Table 33. Global Ambulatory Infusion Therapy Services Sales Value by Application (2027-2032) & (US$ Million)
Table 34. Global Ambulatory Infusion Therapy Services Sales Value Share by Application (2021-2026)
Table 35. Global Ambulatory Infusion Therapy Services Sales Value Share by Application (2027-2032)
Table 36. Global Ambulatory Infusion Therapy Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Global Ambulatory Infusion Therapy Services Sales Value by Region (2021-2026) & (US$ Million)
Table 38. Global Ambulatory Infusion Therapy Services Sales Value Share by Region (2021-2026)
Table 39. Global Ambulatory Infusion Therapy Services Sales Value by Region (2027-2032) & (US$ Million)
Table 40. Global Ambulatory Infusion Therapy Services Sales Value Share by Region (2027-2032)
Table 41. Global Ambulatory Infusion Therapy Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 42. Global Ambulatory Infusion Therapy Services Sales Value by Country (2021-2026) & (US$ Million)
Table 43. Global Ambulatory Infusion Therapy Services Sales Value Market Share by Country (2021-2026)
Table 44. Global Ambulatory Infusion Therapy Services Sales Value by Country (2027-2032) & (US$ Million)
Table 45. Global Ambulatory Infusion Therapy Services Sales Value Market Share by Country (2027-2032)
Table 46. Option Care Health Company Information
Table 47. Option Care Health Business Overview
Table 48. Option Care Health Ambulatory Infusion Therapy Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 49. Option Care Health Ambulatory Infusion Therapy Services Product Portfolio
Table 50. Option Care Health Recent Development
Table 51. Coram CVS Company Information
Table 52. Coram CVS Business Overview
Table 53. Coram CVS Ambulatory Infusion Therapy Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 54. Coram CVS Ambulatory Infusion Therapy Services Product Portfolio
Table 55. Coram CVS Recent Development
Table 56. UnitedHealth Group Company Information
Table 57. UnitedHealth Group Business Overview
Table 58. UnitedHealth Group Ambulatory Infusion Therapy Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 59. UnitedHealth Group Ambulatory Infusion Therapy Services Product Portfolio
Table 60. UnitedHealth Group Recent Development
Table 61. HCA Healthcare Company Information
Table 62. HCA Healthcare Business Overview
Table 63. HCA Healthcare Ambulatory Infusion Therapy Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 64. HCA Healthcare Ambulatory Infusion Therapy Services Product Portfolio
Table 65. HCA Healthcare Recent Development
Table 66. McLaren Company Information
Table 67. McLaren Business Overview
Table 68. McLaren Ambulatory Infusion Therapy Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 69. McLaren Ambulatory Infusion Therapy Services Product Portfolio
Table 70. McLaren Recent Development
Table 71. CHI Health Company Information
Table 72. CHI Health Business Overview
Table 73. CHI Health Ambulatory Infusion Therapy Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 74. CHI Health Ambulatory Infusion Therapy Services Product Portfolio
Table 75. CHI Health Recent Development
Table 76. Accredo Health Company Information
Table 77. Accredo Health Business Overview
Table 78. Accredo Health Ambulatory Infusion Therapy Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 79. Accredo Health Ambulatory Infusion Therapy Services Product Portfolio
Table 80. Accredo Health Recent Development
Table 81. PharMerica Company Information
Table 82. PharMerica Business Overview
Table 83. PharMerica Ambulatory Infusion Therapy Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 84. PharMerica Ambulatory Infusion Therapy Services Product Portfolio
Table 85. PharMerica Recent Development
Table 86. Cleveland Clinic Company Information
Table 87. Cleveland Clinic Business Overview
Table 88. Cleveland Clinic Ambulatory Infusion Therapy Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 89. Cleveland Clinic Ambulatory Infusion Therapy Services Product Portfolio
Table 90. Cleveland Clinic Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Authors List of This Report
Table 93. Secondary Sources
Table 94. Primary Sources
List of Figures
Figure 1. Ambulatory Infusion Therapy Services Product Image
Figure 2. Global Ambulatory Infusion Therapy Services Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Ambulatory Infusion Therapy Services Market Size (2021-2032) & (US$ Million)
Figure 4. Global Ambulatory Infusion Therapy Services Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Anticoagulation therapy Image
Figure 8. Chemotherapy Image
Figure 9. Anti-infective therapies Image
Figure 10. Hydration therapy Image
Figure 11. Immune therapy (Ig) Image
Figure 12. Specialty Injectables Image
Figure 13. IV Steroids Image
Figure 14. Wound Care Image
Figure 15. General Nursing Services Image
Figure 16. Global Ambulatory Infusion Therapy Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 17. Global Ambulatory Infusion Therapy Services Sales Value Share 2021 VS 2025 VS 2032
Figure 18. Global Ambulatory Infusion Therapy Services Sales Value Share by Type (2021-2032)
Figure 19. Hospital Image
Figure 20. Clinic Image
Figure 21. Home Image
Figure 22. Global Ambulatory Infusion Therapy Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 23. Global Ambulatory Infusion Therapy Services Sales Value Share 2021 VS 2025 VS 2032
Figure 24. Global Ambulatory Infusion Therapy Services Sales Value Share by Application (2021-2032)
Figure 25. Global Ambulatory Infusion Therapy Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 26. Global Ambulatory Infusion Therapy Services Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 27. North America Ambulatory Infusion Therapy Services Sales Value (2021-2032) & (US$ Million)
Figure 28. North America Ambulatory Infusion Therapy Services Sales Value Share by Country (%), 2025 VS 2032
Figure 29. Europe Ambulatory Infusion Therapy Services Sales Value (2021-2032) & (US$ Million)
Figure 30. Europe Ambulatory Infusion Therapy Services Sales Value Share by Country (%), 2025 VS 2032
Figure 31. Asia-Pacific Ambulatory Infusion Therapy Services Sales Value (2021-2032) & (US$ Million)
Figure 32. Asia-Pacific Ambulatory Infusion Therapy Services Sales Value Share by Country (%), 2025 VS 2032
Figure 33. South America Ambulatory Infusion Therapy Services Sales Value (2021-2032) & (US$ Million)
Figure 34. South America Ambulatory Infusion Therapy Services Sales Value Share by Country (%), 2025 VS 2032
Figure 35. Middle East & Africa Ambulatory Infusion Therapy Services Sales Value (2021-2032) & (US$ Million)
Figure 36. Middle East & Africa Ambulatory Infusion Therapy Services Sales Value Share by Country (%), 2025 VS 2032
Figure 37. USA Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 38. USA Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 39. USA Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 40. Canada Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 41. Canada Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 42. Canada Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 43. Mexico Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 44. Mexico Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 45. Mexico Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 46. Germany Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 47. Germany Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 48. Germany Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 49. France Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 50. France Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 51. France Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 52. U.K. Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 53. U.K. Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 54. U.K. Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 55. Italy Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 56. Italy Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 57. Italy Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 58. Spain Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 59. Spain Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 60. Spain Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 61. Russia Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 62. Russia Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 63. Russia Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 64. Netherlands Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 65. Netherlands Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 66. Netherlands Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 67. Nordic Countries Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 68. Nordic Countries Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 69. Nordic Countries Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 70. China Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 71. China Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 72. China Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 73. Japan Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 74. Japan Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 75. Japan Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 76. South Korea Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 77. South Korea Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 78. South Korea Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 79. India Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 80. India Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 81. India Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 82. Australia Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 83. Australia Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 84. Australia Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 85. Southeast Asia Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 86. Southeast Asia Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 87. Southeast Asia Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 88. Brazil Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 89. Brazil Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 90. Brazil Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 91. Argentina Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 92. Argentina Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 93. Argentina Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 94. Chile Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 95. Chile Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 96. Chile Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 97. Colombia Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 98. Colombia Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 99. Colombia Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 100. Peru Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 101. Peru Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 102. Peru Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 103. Saudi Arabia Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 104. Saudi Arabia Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 105. Saudi Arabia Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 106. Israel Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 107. Israel Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 108. Israel Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 109. UAE Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 110. UAE Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 111. UAE Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 112. Turkey Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 113. Turkey Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 114. Turkey Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 115. Iran Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 116. Iran Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 117. Iran Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 118. Egypt Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 119. Egypt Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 120. Egypt Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 121. Years Considered
Figure 122. Research Process
Figure 123. Key Executives Interviewed
Scope & coverage.
Types
- Anticoagulation therapy
- Chemotherapy
- Anti-infective therapies
- Hydration therapy
- Immune therapy (Ig)
- Specialty Injectables
- IV Steroids
- Wound Care
- General Nursing Services
Applications
- Hospital
- Clinic
- Home
Companies covered
- Option Care Health
- Coram CVS
- UnitedHealth Group
- HCA Healthcare
- McLaren
- CHI Health
- Accredo Health
- PharMerica
- Cleveland Clinic
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Ambulatory Infusion Therapy Services Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Ambulatory Infusion Therapy Services Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Ambulatory Infusion Therapy Services Market Dynamics
- 2.1 Ambulatory Infusion Therapy Services Industry Trends
- 2.2 Ambulatory Infusion Therapy Services Industry Drivers
- 2.3 Ambulatory Infusion Therapy Services Industry Opportunities and Challenges
- 2.4 Ambulatory Infusion Therapy Services Industry Restraints
3 Ambulatory Infusion Therapy Services Market by Company
- 3.1 Global Ambulatory Infusion Therapy Services Company Revenue Ranking in 2025
- 3.2 Global Ambulatory Infusion Therapy Services Revenue by Company (2021-2026)
- 3.3 Global Ambulatory Infusion Therapy Services Company Ranking (2024-2026)
- 3.4 Global Ambulatory Infusion Therapy Services Company Manufacturing Base and Headquarters
- 3.5 Global Ambulatory Infusion Therapy Services Company Product Type and Application
- 3.6 Global Ambulatory Infusion Therapy Services Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Ambulatory Infusion Therapy Services Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Ambulatory Infusion Therapy Services Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Ambulatory Infusion Therapy Services Market by Type
- 4.1 Ambulatory Infusion Therapy Services Type Introduction
- 4.1.1 Anticoagulation therapy
- 4.1.2 Chemotherapy
- 4.1.3 Anti-infective therapies
- 4.1.4 Hydration therapy
- 4.1.5 Immune therapy (Ig)
- 4.1.6 Specialty Injectables
- 4.1.7 IV Steroids
- 4.1.8 Wound Care
- 4.1.9 General Nursing Services
- 4.2 Global Ambulatory Infusion Therapy Services Sales Value by Type
- 4.2.1 Global Ambulatory Infusion Therapy Services Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Ambulatory Infusion Therapy Services Sales Value by Type (2021-2032)
- 4.2.3 Global Ambulatory Infusion Therapy Services Sales Value Share by Type (2021-2032)
5 Ambulatory Infusion Therapy Services Market by Application
- 5.1 Ambulatory Infusion Therapy Services Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Home
- 5.2 Global Ambulatory Infusion Therapy Services Sales Value by Application
- 5.2.1 Global Ambulatory Infusion Therapy Services Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Ambulatory Infusion Therapy Services Sales Value by Application (2021-2032)
- 5.2.3 Global Ambulatory Infusion Therapy Services Sales Value Share by Application (2021-2032)
6 Ambulatory Infusion Therapy Services Regional Value Analysis
- 6.1 Global Ambulatory Infusion Therapy Services Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Ambulatory Infusion Therapy Services Sales Value by Region (2021-2032)
- 6.2.1 Global Ambulatory Infusion Therapy Services Sales Value by Region: 2021-2026
- 6.2.2 Global Ambulatory Infusion Therapy Services Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Ambulatory Infusion Therapy Services Sales Value (2021-2032)
- 6.3.2 North America Ambulatory Infusion Therapy Services Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Ambulatory Infusion Therapy Services Sales Value (2021-2032)
- 6.4.2 Europe Ambulatory Infusion Therapy Services Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Ambulatory Infusion Therapy Services Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Ambulatory Infusion Therapy Services Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Ambulatory Infusion Therapy Services Sales Value (2021-2032)
- 6.6.2 South America Ambulatory Infusion Therapy Services Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Ambulatory Infusion Therapy Services Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Ambulatory Infusion Therapy Services Sales Value Share by Country, 2025 VS 2032
7 Ambulatory Infusion Therapy Services Country-level Value Analysis
- 7.1 Global Ambulatory Infusion Therapy Services Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Ambulatory Infusion Therapy Services Sales Value by Country (2021-2032)
- 7.2.1 Global Ambulatory Infusion Therapy Services Sales Value by Country (2021-2026)
- 7.2.2 Global Ambulatory Infusion Therapy Services Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.7.2 France Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.14.2 China Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.17.2 India Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Ambulatory Infusion Therapy Services Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Ambulatory Infusion Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Ambulatory Infusion Therapy Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Option Care Health
- 8.1.1 Option Care Health Company Information
- 8.1.2 Option Care Health Business Overview
- 8.1.3 Option Care Health Ambulatory Infusion Therapy Services Revenue and Gross Margin (2021-2026)
- 8.1.4 Option Care Health Ambulatory Infusion Therapy Services Product Portfolio
- 8.1.5 Option Care Health Recent Developments
- 8.2 Coram CVS
- 8.2.1 Coram CVS Company Information
- 8.2.2 Coram CVS Business Overview
- 8.2.3 Coram CVS Ambulatory Infusion Therapy Services Revenue and Gross Margin (2021-2026)
- 8.2.4 Coram CVS Ambulatory Infusion Therapy Services Product Portfolio
- 8.2.5 Coram CVS Recent Developments
- 8.3 UnitedHealth Group
- 8.3.1 UnitedHealth Group Company Information
- 8.3.2 UnitedHealth Group Business Overview
- 8.3.3 UnitedHealth Group Ambulatory Infusion Therapy Services Revenue and Gross Margin (2021-2026)
- 8.3.4 UnitedHealth Group Ambulatory Infusion Therapy Services Product Portfolio
- 8.3.5 UnitedHealth Group Recent Developments
- 8.4 HCA Healthcare
- 8.4.1 HCA Healthcare Company Information
- 8.4.2 HCA Healthcare Business Overview
- 8.4.3 HCA Healthcare Ambulatory Infusion Therapy Services Revenue and Gross Margin (2021-2026)
- 8.4.4 HCA Healthcare Ambulatory Infusion Therapy Services Product Portfolio
- 8.4.5 HCA Healthcare Recent Developments
- 8.5 McLaren
- 8.5.1 McLaren Company Information
- 8.5.2 McLaren Business Overview
- 8.5.3 McLaren Ambulatory Infusion Therapy Services Revenue and Gross Margin (2021-2026)
- 8.5.4 McLaren Ambulatory Infusion Therapy Services Product Portfolio
- 8.5.5 McLaren Recent Developments
- 8.6 CHI Health
- 8.6.1 CHI Health Company Information
- 8.6.2 CHI Health Business Overview
- 8.6.3 CHI Health Ambulatory Infusion Therapy Services Revenue and Gross Margin (2021-2026)
- 8.6.4 CHI Health Ambulatory Infusion Therapy Services Product Portfolio
- 8.6.5 CHI Health Recent Developments
- 8.7 Accredo Health
- 8.7.1 Accredo Health Company Information
- 8.7.2 Accredo Health Business Overview
- 8.7.3 Accredo Health Ambulatory Infusion Therapy Services Revenue and Gross Margin (2021-2026)
- 8.7.4 Accredo Health Ambulatory Infusion Therapy Services Product Portfolio
- 8.7.5 Accredo Health Recent Developments
- 8.8 PharMerica
- 8.8.1 PharMerica Company Information
- 8.8.2 PharMerica Business Overview
- 8.8.3 PharMerica Ambulatory Infusion Therapy Services Revenue and Gross Margin (2021-2026)
- 8.8.4 PharMerica Ambulatory Infusion Therapy Services Product Portfolio
- 8.8.5 PharMerica Recent Developments
- 8.9 Cleveland Clinic
- 8.9.1 Cleveland Clinic Company Information
- 8.9.2 Cleveland Clinic Business Overview
- 8.9.3 Cleveland Clinic Ambulatory Infusion Therapy Services Revenue and Gross Margin (2021-2026)
- 8.9.4 Cleveland Clinic Ambulatory Infusion Therapy Services Product Portfolio
- 8.9.5 Cleveland Clinic Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst